Beryl Drugs Ltd. - Research Center
524606 BERLDRG Group (X) BSE data
Results
|
Half yearly
|
Statement
|
|
More
|
|
Half yearly results in brief
(Rs crore)
|
Sep ' 23 |
Sep ' 22 |
Mar ' 22 |
Sep ' 21 |
Sep ' 20 |
Sales |
16.13 |
12.62 |
6.65 |
7.95 |
5.97 |
Operating profit |
1.73 |
0.97 |
-0.13 |
0.54 |
0.68 |
Interest |
0.22 |
0.24 |
0.21 |
0.22 |
0.23 |
Gross profit |
1.63 |
0.99 |
-0.26 |
0.39 |
0.99 |
EPS (Rs) |
1.59 |
1.10 |
-1.14 |
-0.16 |
0.58 |
Half yearly
results in details
|
Sep ' 23 |
Sep ' 22 |
Mar ' 22 |
Sep ' 21 |
Sep ' 20 |
Other income |
0.12 |
0.25 |
0.09 |
0.08 |
0.54 |
Stock adjustment |
-0.01 |
-0.02 |
-0.39 |
0.08 |
-0.37 |
Raw material |
6.92 |
7.18 |
4.50 |
4.21 |
3.52 |
Power and fuel |
- |
- |
- |
- |
- |
Employee expenses |
0.89 |
0.78 |
0.68 |
0.63 |
0.52 |
Excise |
- |
- |
- |
- |
- |
Admin and selling expenses |
- |
- |
- |
- |
- |
Research and development expenses |
- |
- |
- |
- |
- |
Expenses capitalised |
- |
- |
- |
- |
- |
Other expenses |
6.60 |
3.71 |
1.99 |
2.49 |
1.62 |
Provisions made |
- |
- |
- |
- |
- |
Depreciation |
0.58 |
0.44 |
0.54 |
0.54 |
0.69 |
Taxation |
0.25 |
-0.01 |
-0.22 |
-0.07 |
0.01 |
Net profit / loss |
0.80 |
0.56 |
-0.58 |
-0.08 |
0.29 |
Extra ordinary item |
- |
- |
- |
- |
- |
Prior year adjustments |
- |
- |
- |
- |
- |
Equity capital |
5.07 |
5.07 |
5.07 |
5.07 |
5.07 |
Equity dividend rate |
- |
- |
- |
- |
- |
Agg.of non-prom. shares (Lacs) |
- |
- |
- |
- |
- |
Agg.of non promotoholding (%) |
- |
- |
- |
- |
- |
OPM (%) |
10.70 |
7.72 |
-1.99 |
6.79 |
11.43 |
GPM (%) |
10.05 |
7.66 |
-3.82 |
4.90 |
15.25 |
NPM (%) |
4.95 |
4.35 |
-8.55 |
-1.03 |
4.50 |